undamentalytics Newsletter
Sign in

Callan JMB Inc. (CJMB) stock

Add to watchlist

Add holding +

NASDAQ: CJMB Nasdaq Diversified Support Services

Callan JMB Inc. is a US-listed company in the diversified support services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$0.4

Price-to-sales vs peers

Base case. Range ~$0.3–$2.2. Sales per share times peers' typical price-to-sales; used only when earnings are negative.

Price vs value

No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Callan JMB Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders4 buying, 0 selling13 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds7 adding, 7 cuttingOf 1 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Callan JMB files

Where Callan JMB stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $5m. Free-cash-flow margin fell to -93.1% from -39.1% a year earlier. Operating margin narrowed to -146.1% from -79.6%. It passes 1 of our 3 financial-health checks. Our price-to-sales vs peers value is $0.62 a share, against a share price of $0.48.

Source: 10-Q filed August 14, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Callan JMB Inc.'s trailing-twelve-month revenue fell 13.8% year on year, with a free-cash-flow margin of -93.1%.

Current signal Net margin compressing: TTM net margin fell to -192.0%, down 111.6pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Revenue shrinking. Revenue fell 13.8% over the last 12 months.
  • Loss-making. Operating margin is -146.1%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 66.5 points on a year ago.
  • Burning cash. Free cash flow was -93.1% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 29.8% of revenue: a real cost that cash-flow figures leave out.
  • Volatile shares. Over the past year the shares showed annualised volatility of 316% and a beta of 0.6 against the S&P 500.

Latest results: FY2026 Q2

Filed August 14, 2026
Revenue
$1m, down 17.4% on a year earlier

Callan JMB's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-16.6%
  • 1 week-28.4%
  • 1 month-85.6%
  • This year-68.4%
  • 1 year-91.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$5.1M
Operating margin
-146.1%
Net margin
-192.0%
EPS (TTM, diluted)
$-2.38

Growth

Revenue growth
−13.8%
Change in growth rate
−0.2 pts

Cash

Free cash flow (TTM)
-$4.7M
FCF margin
-93.1%
Stock pay % of revenue
29.8%

Earnings

Last results
March 31, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Leadership
  3. Agreement
  4. Agreement
  5. Agreement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Callan JMB Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation models

We value Callan JMB Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.81 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$0.4 ~$0.3–$2.2 Included, half weight
Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$0.4 ~$0.3–$2.2 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Callan JMB Inc. with Diversified Support Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 2025
Share price$1.11
Market value$5m
+ Net debt (− = net cash)−$2m
Enterprise value$3m
Multiples
Price / sales 0.8x
Price / earnings —
Price / free cash flow —
EV / EBITDA —

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Callan JMB Inc.: too few analysts cover it.

Management guidance

Earnings release, March 31, 2026

No numeric guidance in Callan JMB Inc.'s latest earnings release (filed March 31, 2026). Some companies give their outlook only on the earnings call.

Positioning

Short interest
2.9%
of tradable shares
Days to cover
1.34
at average volume
Short interest, 1 month
−8%
to October 15, 2026
Held by institutions
10%
of shares
Held by insiders
56.4%
of shares
Employees
18
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −91.3%

$4.02 on October 31, 2025 to $0.35

ThenNowEffect
Revenue (last 12 months) $6m $5m −13.8%
P/S multiple 2.5x 0.3x −87.5%
Share count 4m 5m −19.1%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 2026 to date
Return
CJMB−68%
Industry peers (median)−10%
S&P 500+11%
Months that ended higher
CJMB46%
S&P 50046%
Largest fall from a high during the year
CJMB−92%
S&P 500−9%

Worst fall since February 5, 2025: 94% from February 6, 2025 to November 2, 2026. Getting back needed a 1701% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.35 – $4.20
From 52-week high
−91.6%
vs 50-day average
−81.4%
vs 200-day average
−77.2%
Volatility (1 year)
316%
Beta vs S&P 500
0.64

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 0 down
typical move ±6.7%
After a week
2 up, 2 down
typical move ±7.5%
After a month
1 up, 3 down
typical move ±17.7%
Results releasedNext dayS&P 500 next day5 days21 days
March 31, 2026 +6.9% +3.7% +8.6% −4.3%
November 14, 2025 +8.7% −0.9% −11.9% −48.5%
August 14, 2025 +1.2% −0.2% 0.0% +1.3%
May 15, 2025 +10.1% +1.1% +9.7% −16.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Callan JMB Inc.
$5M $5.5M $6M $6.5M $7M FY24 Q4 FY25 Q2 FY25 Q4 FY26 Q2 Revenue (TTM), FY24 Q4: $6.6M Revenue (TTM), FY25 Q1: $6.2M Revenue (TTM), FY25 Q2: $5.9M Revenue (TTM), FY25 Q3: $5.9M Revenue (TTM), FY25 Q4: $5.7M Revenue (TTM), FY26 Q1: $5.4M Revenue (TTM), FY26 Q2: $5.1M $5.1M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY24 Q4 $6.6M
FY25 Q1 $6.2M
FY25 Q2 $5.9M
FY25 Q3 $5.9M
FY25 Q4 $5.7M
FY26 Q1 $5.4M
FY26 Q2 $5.1M
Operating margin (TTM) Callan JMB Inc.
-150% -100% -50% 0% FY24 Q4 FY25 Q2 FY25 Q4 FY26 Q2 Operating margin (TTM), FY24 Q4: -34.7% Operating margin (TTM), FY25 Q1: -55.1% Operating margin (TTM), FY25 Q2: -79.6% Operating margin (TTM), FY25 Q3: -98.0% Operating margin (TTM), FY25 Q4: -122.9% Operating margin (TTM), FY26 Q1: -139.4% Operating margin (TTM), FY26 Q2: -146.1% -146.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q4 -34.7%
FY25 Q1 -55.1%
FY25 Q2 -79.6%
FY25 Q3 -98.0%
FY25 Q4 -122.9%
FY26 Q1 -139.4%
FY26 Q2 -146.1%
FCF margin (TTM) Callan JMB Inc.
-100% -50% 0% 50% FY24 Q4 FY25 Q2 FY25 Q4 FY26 Q2 FCF margin (TTM), FY24 Q4: 7.5% FCF margin (TTM), FY25 Q1: -16.8% FCF margin (TTM), FY25 Q2: -39.1% FCF margin (TTM), FY25 Q3: -88.4% FCF margin (TTM), FY25 Q4: -90.2% FCF margin (TTM), FY26 Q1: -98.6% FCF margin (TTM), FY26 Q2: -93.1% -93.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q4 7.5%
FY25 Q1 -16.8%
FY25 Q2 -39.1%
FY25 Q3 -88.4%
FY25 Q4 -90.2%
FY26 Q1 -98.6%
FY26 Q2 -93.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 13 7 6 5
Gross profit 6 3 2 2
EBITDA 2 −2 −7 −7
Operating income 2 −2 −7 −7
Net income 2 −2 −8 −10
Diluted EPS — −$0.87 −$1.82 —
Growth (year on year)
Revenue — −50.3% −12.8% −13.8%
EBITDA — −192.5% — —
Operating income — −203.3% — —
Net income — −205.2% — —
Margins
Gross margin 42.8% 39.1% 36.8% 39.9%
EBITDA margin 17.5% −32.5% −120.3% −143.2%
Operating margin 16.7% −34.7% −122.9% −146.1%
Net margin 16.5% −34.9% −139.2% −192.0%
Free-cash-flow margin 49.3% 7.5% −90.2% −93.1%
Cash flow
Cash from operations 7 1 −5 −4
Capital spending 0 0 1 0
Free cash flow 7 0 −5 −5
Stock-based pay — — 2 2
Free cash flow after stock pay — — −7 −6
Balance sheet
Cash 5 2 2 1
Total debt 0 0 0 0
Net debt (negative = net cash) −5 −2 −2 −1
Diluted shares — 3m 4m —
Returned to shareholders
Dividends 7 3 — —
Total returned 7 3 — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 3 checks passed · June 30, 2026
What it owns · $4m
Short-term assets $2mLonger-term assets $3m
What it owes, and who funded it · $4m
Short-term liabilities $1mLonger-term liabilities $2mShareholders' equity $1m
  • Short-term assets cover short-term liabilities $2m of assets due within a year against $1m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $2m short-term assets against $2m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$7m against $2,675 of interest.

From Callan JMB Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Sales & admin spending
175.4%
of revenue
Days sales outstanding
19 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in diversified support services
Last 12 months unless stated CJMB TGL ANPA DPU OCG HCAI Median
Revenue, last 12 months $5m $5m $6m $8m $2m $15m $808m
Revenue growth, last 12 months −13.8% 121.8% 6.2% 114.3% 203.3% −63.6% 6.2%
Revenue growth, latest quarter −17.4% 108.3% — — — — 7.1%
Gross margin 39.9% 0.2% 46.2% 8.7% 85.7% 2.7% 31.5%
Operating margin −146.1% −317.7% 1.6% −301.6% −203.5% −142.5% 4.5%
Net margin −192.0% −214.4% 2.1% −298.8% −204.2% −283.6% 2.1%
Cash from operations / revenue −88.4% −133.2% 6.0% −16.1% 4.1% −8.7% 7.0%
Free-cash-flow margin −93.1% −153.5% −2.9% −16.2% 4.1% −8.7% 3.4%
Stock pay / revenue 29.8% 35.7% — 42.1% 200.7% 140.4% 1.4%
Change in share count — — 2.6% 325.3% −99.8% 12.6% 0.1%

Median of all 33 companies we cover in diversified support services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Emergency Preparedness $4M 69.5% ▲ 4.8%
Specialty Packaging $1.7M 30.5% ▼ 36.9%

From Callan JMB Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$499,407
Institutions reporting
14
Shares held vs prior quarter
▲ 4.2%
Positions opened / closed
6 / 3

Top buyers and sellers, Q2 2026: 7 institutions bought and 7 sold ; the biggest buyer was Citadel Advisors LLC (+32K shares) and the biggest seller Jane Street Group, LLC (−28K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Creative Planning $205,577 256K 41.2% 0.0%
Bard Associates Inc $184,317 229K 36.9% ▼ 6.6%
Citadel Advisors LLC $25,797 32K 5.2% New
Axxcess Wealth Management, LLC $20,100 25K 4.0% New
Geode Capital Management, LLC $12,599 16K 2.5% ▼ 31.8%
Financial Plan, Inc. $10,854 14K 2.2% New
Citigroup Inc $10,792 13K 2.2% New
Hightower Advisors, LLC $10,050 13K 2.0% 0.0%
Xtx Topco Ltd $9,075 11K 1.8% New
Vanguard Capital Management LLC $5,358 7K 1.1% 0.0%
UBS Group AG $4,537 6K 0.9% ▲ 245.3%
Tower Research Capital LLC (TRC) $349 0K 0.1% ▼ 79.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Callan JMB Inc.'s complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $165,499 13 trades by 4 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $165,499 net buying
Insider Date Trade Shares Price Value
Croyle David J Chief Medical Officer March 20, 2026 Buy 10,195 $1.75 $17,841
Croyle David J Chief Medical Officer March 6, 2026 Buy 14,805 $1.76 $26,057
Dial Gerald Director December 30, 2025 Buy 10,000 $0.76 $7,600
Dial Gerald Director December 30, 2025 Buy 461 $1.22 $562
Dial Gerald Director December 30, 2025 Buy 1,539 $1.20 $1,847
Williams Wayne D CEO, Chairman and President December 16, 2025 Buy 5,000 $1.73 $8,650
Williams Wayne D CEO, Chairman and President December 15, 2025 Buy 10,810 $1.70 $18,377
Williams Wayne D CEO, Chairman and President December 12, 2025 Buy 4,926 $1.75 $8,620
Williams Wayne D CEO, Chairman and President December 11, 2025 Buy 30,856 $1.65 $50,912
Williams Wayne D CEO, Chairman and President December 11, 2025 Buy 62 $1.79 $111
Williams Wayne D CEO, Chairman and President December 10, 2025 Buy 13,689 $1.65 $22,587
Duke Liberty Smith Director December 9, 2025 Buy 612 $1.52 $930

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around July 1, 2026 estimated from the company's past filing pattern, not announced

  • March 31, 2026
  • November 14, 2025
  • August 14, 2025
  • May 15, 2025

Recent SEC filings

Data status

When each part of this page on Callan JMB Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Callan JMB Inc. in brief

What does Callan JMB Inc. do?
Callan JMB Inc. is a US-listed company in the diversified support services industry. Its financial year ends in December.
What is Callan JMB Inc.'s stock ticker?
Callan JMB Inc. trades under the ticker CJMB on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Callan JMB Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Callan JMB Inc. reported revenue of $5.1M, 13.8% lower than a year earlier, according to its SEC filings.
What is Callan JMB Inc.'s free cash flow?
Callan JMB Inc.'s free-cash-flow margin is -93.1% of revenue over the trailing twelve months.
Who are Callan JMB Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Creative Planning, Bard Associates Inc and Citadel Advisors LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Callan JMB Inc.'s market cap?
On December 31, 2025, Callan JMB Inc.'s market capitalisation was about $4.9M and net debt of -$2.1M. Market figures come from third-party market data and may be delayed.
Who are Callan JMB Inc.'s competitors?
In our Diversified Support Services peer group, the companies closest to Callan JMB Inc. are Treasure Global Inc, Rich Sparkle Holdings Ltd, Nexpu Ltd., Oriental Culture Holding LTD and Huachen AI Parking Management Technology Holding Co., Ltd. The side-by-side comparison below sets their revenue, margins and growth against Callan JMB Inc.'s.
Are insiders buying or selling Callan JMB Inc. stock?
Over the last 12 months, Callan JMB Inc.'s directors and officers reported 13 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.